Value in Health contains original research articles for pharmacoeconomics, health economics, and outcomes research (clinical, economic, and patient-reported outcomes/preference-based research), as well as conceptual and health policy articles that provide valuable information for health care decision-makers as well as the research community. As the official journal of ISPOR, Value in Health provides a forum for researchers, as well as health care decision-makers to translate outcomes research into health care decisions. 

 original research articles

Editors-in-Chief
Michael Drummond, PhD
University of York Centre for Health Economics, York, United Kingdom
C. Daniel Mullins, PhD
University of Maryland at College Park, Baltimore, MD, United States
Associate Editors
Sarah Acaster, PSc, MSc
Acaster Lloyd Consulting Limited, London, United Kingdom
Kalipso Chalkidou, MD, PhD
NICE International, London, United Kingdom
Joshua P. Cohen, PhD
Tufts Center for the Study of Drug Development, Boston, Massachusetts, United States
Jalpa Doshi, PhD
University of Pennsylvania Population Studies Center, Philadelphia, Pennsylvania, United States
David Epstein, MSc, PhD
Universidad de Granada, Departamento de Economia Aplicada, Granada, Spain
Manuel Espinoza, PhD, MD, MSc
Pontifical Catholic University of Chile, Santiago, Chile
Alex Fu, PhD
Georgetown University, Washington, District of Columbia, United States
Ron Goeree, MA
McMaster University, Hamilton, Ontario, Canada
Fei-Yuan Sharon Hsiao, PhD
National Taiwan University, Taipei, Taiwan
Stacie Hudgens, MA
Clinical Outcomes Solutions LLC, Tucson, Arizona, United States
Andrew Lloyd, Dphil, BSc
Oxford Outcomes, Oxford, England, United Kingdom
Lori McCleod, PhD
RTI Health Solutions Research Triangle Park, Research Triangle Park, North Carolina, United States
Claire Rothery Mckenna, PhD
University of York, York, United Kingdom
Axel Muehlbacher, PhD
University of Applied Sciences Neubrandenburg, Neubrandenburg, Germany
Richard Norman
Curtin University, Perth, Western Australia, Australia
Maarten Postma, PhD
University of Groningen, Groningen, Netherlands
Thomas Rapp, PhD
Harvard University, Cambridge, Massachusetts, United States
Lizheng Shi, PhD, MsPharm, MA
Tulane University, New Orleans, Louisiana, United States
Aleksandra Torbica, PhD
Bocconi University, Milano, Italy
David Vanness, PhD
Pennsylvania State University, University Park, Pennsylvania, United States
David Veenstra, PhD, PharmD
University of Washington, Seattle, Washington, United States
Allan Wailoo, PhD, BSc, MA
The University of Sheffield, Sheffield, United Kingdom
Danielle Whicher, PhD, MHS
Patient-Centered Outcomes Research Institute, Washington, United States
Editorial Advisory Board
Alan Brennan, PhD
The University of Sheffield, Sheffield, England, United Kingdom
John Hornberger, PhD, MS
Cedar Associates, Menlo Park, California, United States
John Hsu, PhD
Harvard University, Cambridge, Massachusetts, United States
Andrea Manca, PhD, MSc
University of York, York, United Kingdom
Robert Ohsfeldt, PhD
Texas A&M University College Station, College Station, Texas, United States
Kathryn A. Phillips, PhD
University of California San Francisco, San Francisco, California, United States
Shelby Reed, PhD, RPH
DUKE CLINICAL RESEARCH INSTITUTE, Durham, North Carolina, United States
Brian Rittenhouse, PhD
Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, United States
Paul Scuffham, PhD, BA
Griffith University School of Medicine - Logan Campus, Meadowbrook, Queensland, Australia
Johan L. Severens, PhD
Erasmus University Rotterdam, Rotterdam, Netherlands
Ya-Chen (Tina) Shih, PhD
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER, Houston, Texas, United States
Director, Publications
Stephen L. Priori
International Society for Pharmacoeconomics and Outcomes Research, Lawrenceville, New Jersey, United States